期刊文献+

布地奈特联合氨溴索雾化吸入对AECOPD的排痰效果观察 被引量:5

Observation on pulmicort with ambroxol inhalation of foggy in the treatment of chronic obstructive pulmonary disease at acute exacerbation phase
在线阅读 下载PDF
导出
摘要 目的探讨布地奈特联合氨溴索雾化吸入对AECOPD的排痰效果。方法将100例AE-COPD患者随机分为观察组和对照组,各50例。观察组用生理盐水5ml+氨溴索30mg+布地奈特1mg氧驱动雾化吸入,2次/d,10~14d。对照组用生理盐水5ml+氨溴索30mg氧驱动雾化吸入,2次/d,10~14d。观察两组患者治疗前后的日排痰量、末梢静脉血氧饱和度、临床症状评分、肺功能、全身应用糖皮质激素总量、平均住院日及不良反应。结果两组比较各项观察指标均有明显改善(P<0.05),无不良反应发生。结论氨溴索联合布地奈特雾化吸入能促进排痰,改善临床症状,减少全身糖皮质激素用量,缩短住院日而且无明显不良反应。 Objective To observe effect of pulmicort with Ambroxol inhalation on AECOPD.Methods 100 patients with AECOPD were randomly divided into two groups( the observation group and the control group) . The observation on group given pulmicort with Ambroxol by nebulizer,the control group given Ambroxol by nebulizer,bid,10 ~ 14 day. Results There were significant improvement of all sputum amount everyday, clinical symptonscore,SpO2,be in hospital days relevant paraneters of two groups after therapy( 〈0. 01) . Conclusion It was markednes that the treatment effect of pulmicort with ambroxol inhalation of foggy on AECOPD.
作者 卢庆润
出处 《中国实用医药》 2010年第26期8-9,共2页 China Practical Medicine
关键词 布地奈特 氨溴索 雾化吸入 慢性阻塞性肺疾病急性期 Pulmicort Ambroxol Inhalation of foggy AECOPD
  • 相关文献

参考文献4

二级参考文献26

  • 1沈莹,刘呈芳,王光田,夏勇.应用超声雾化吸入经气道补钾补镁的实验研究[J].中华护理杂志,1994,29(10):579-583. 被引量:17
  • 2有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:280
  • 3蔡文化 高治庆.哮喘患者长期吸入糖皮质激素50例疗效观察[J].中国实用内科杂志,2001,21(3):144-144.
  • 4[2]Casaburi R,Briggs DD Jr,Donohue JF,et al.The spirometric efficacy of once-daily dosing with tiotropium in stable COPD:a 13-week multicenter trial.The US Tiotropium Study Group[J].Chest,2000,118(5):1294~1302.
  • 5[3]Niewoehner DE.The role of systemic corticosteroids in acute exacerbation ofchronic obstructive pulmonary disease[J].Am J Respir Med,2002,1(4):243~248.
  • 6[4]Walsh LJ,Lewis SA,Wong CA,et al.The impact of oral corticosteroid use on bonemineral density and vertebral fracture[J].Am J Respir Crit Care Med,2002,166(5):691~695.
  • 7[5]Szefler SJ,Lyzell E,Fitzpatrick S,et al.Safety profile of budesonide inhalation suspension in the pediatric population:worldwide experience[J].Ann Allergy Asthma Immunol,2004,93(1):83~90.
  • 8[6]Maltais F,Ostinelli J,Bourbeau J,et al.Comparison of nebulized budesonide and oral prednisolone wish placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease:a randomized controlled trial[J].Am J Repir Crit Care Med,2002,165(5):698~703.
  • 9[7]Mirici A,et al.Comparison of the efficacy of nebulised budesonide with parenteral corticosteroids in the treatment of AECOPD[J].Clin Drug Invest,2003,23:55~62.
  • 10[8]Renkema TE,Schouten JP,Koeter GH,et al.Effects of longterm treatment with corticosteroids in COPD[J].Chest,1996,109(5):115~1162.

共引文献8402

同被引文献38

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部